Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases
2015 (English)In: Cancer Metastasis Review, ISSN 0167-7659, E-ISSN 1573-7233, Vol. 34, no 4, 611-618 p.Article in journal (Refereed) Published
BRMS1 was discovered over a decade ago as a potential tumor suppressor gene. In this review, we summarize the recent findings about the structure of BRMS1, mechanisms of its action and a role of BRMS1 in the cancer progression. As a suppressor of metastasis, BRMS1 has demonstrated a variety of ways to act on the cell functions, such as cell migration, invasiveness, angiogenesis, cell survival, cytoskeleton rearrangements, cell adhesion, and immune recognition. This variety of effects is a likely reason behind the robustness of anti-metastatic influence of BRMS1. Intracellular signaling mechanisms employed by BRMS1 include regulation of transcription, EGF/HER2 signaling, and expression of NF-kB, fascin, osteopontin, and IL-6. Recently reported clinical studies confirm that BRMS1 can indeed be used as a prognostic marker. Approaches to employ BRMS1 in a development of anti-cancer treatment have also been made. The studies reviewed here with respect to BRMS1 structure, cellular effects, intracellular signaling, and clinical value consolidate the importance of BRMS1 in the development of metastasis.
Place, publisher, year, edition, pages
Springer Science+Business Media B.V., 2015. Vol. 34, no 4, 611-618 p.
Cell and Molecular Biology
IdentifiersURN: urn:nbn:se:kth:diva-174600DOI: 10.1007/s10555-015-9583-zISI: 000365705800005PubMedID: 26328523ScopusID: 2-s2.0-84958849279OAI: oai:DiVA.org:kth-174600DiVA: diva2:877338
QC 201512072015-12-072015-10-072016-01-15Bibliographically approved